13F filer · CIK 2013410
FCPM III SERVICES B.V.
NAARDEN, P7 · filing since Q4 2023 · last filing Aug 14, 2026
Reported value
$750.4M
+$28.2M vs prior
Positions
11
New / sold out
1 / 0
Added / reduced
0 / 2
Turnover
3.9%
buys $28.8M · sells $41.7M
Top-10 weight
99.9%
Biggest buys vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| New | AURA BIOSCIENCES INC | +4,053,775 | – | +$28.8M |
Biggest sells vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Reduced | NEWAMSTERDAM PHARMA COMPANY | -708,547 | -7.7% | $-24.0M |
| Reduced | DYNE THERAPEUTICS INC | -796,130 | -17.1% | $-17.7M |
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2026
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | NEWAMSTERDAM PHARMA COMPANYORDINARY SHARES | 8,490,353 | $287.7M | 38.34% |
| 2 | MAPLIGHT THERAPEUTICS INCCOM | 3,226,400 | $115.6M | 15.41% |
| 3 | DYNE THERAPEUTICS INCCOM | 3,848,256 | $85.5M | 11.39% |
| 4 | VOR BIOPHARMA INCCOM NEW | 4,117,354 | $75.8M | 10.10% |
| 5 | DAMORA THERAPEUTICS INCCOM NEW | 2,441,000 | $63.5M | 8.46% |
| 6 | REPLIMUNE GROUP INCCOM | 2,808,368 | $31.1M | 4.14% |
| 7 | CRESCENT BIOPHARMA INC.COM | 1,677,852 | $30.2M | 4.02% |
| 8 | AURA BIOSCIENCES INCCOM | 4,053,775 | $28.8M | 3.84% |
| 9 | ENGENE HOLDINGS INCCOM | 9,632,561 | $16.7M | 2.22% |
| 10 | BICYCLE THERAPEUTICS PLCSPONSORED ADS | 3,468,430 | $14.7M | 1.96% |
1 more rows. Subscribe for $29/month to see every row, download the data and use the API.